Safety and Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Single Center Experience

Pan X, Wu SJ, Tang Y, Zhou YF, Luo JW, Fang ZT

Journal of Hepatocellular Carcinoma 2023, 10:883-892

Published Date: 9 June 2023